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Abstract
In our commentary on Lynch et al.’s target paper (2019, this issue), we focus on decom-
position as a research strategy. We argue that not only the presumptive microbial causes
but also their supposed phenotypic effects need to be decomposed relative to each other.
Such a dual decomposition strategy ought to improve the way in which causal claims in
microbiome research can be made and understood.
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Causal claims of the form ‘the microbiome µ causes phenotype ϕ’ can be frequently found
in microbiome research. Lynch et al. (2019, this issue) discuss a number of difficulties with
attempts to establish causality between the microbiome and phenotypes of their host. One of
the main problems they address – as also recently pointed out by (Bourrat, 2018; Parke et al.,
2018; O’Malley and Skillings, 2018) – is the usage of the mass term ‘the microbiome’ in causal
claims, which leaves unclear what the actual causal agents are. Only in exceptional cases will
the entirety of microbial entities, components, and activities collectively be responsible for
bringing about the phenotype in question. Thus, Lynch et al. emphasize the importance of
decomposing “the microbiome into component parts that can be understood independently”
(2019, 20) for identifying the microbiome’s causally relevant components. While we agree
with the importance of decomposition, we want to argue for a dual decomposition strategy in
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order to improve causal claims. The following paragraphs address some of the issues related
to this dual decomposition strategy.
(i) We suspect that many biologists are already aware of the importance of decomposing the
microbiome as a causal entity and just talk about it as a reified unit in non-technical contexts
or for heuristic purposes. The authors acknowledge that as a possibility in the final paragraphs
of their paper (Lynch et al., 2019, 22). With a charitable reading, undecomposed claims could
be understood as placeholder claims: there exist some activities of certain types of microbes
within the microbiome that causally contribute in such-and-such a way to the particular aspect
of a phenotype. Blaming the chicken sandwich for poisoning before observing the presence
of a heavy load of Salmonella (Bourrat, 2018), is, after all, neither naivety nor necessarily a
bad strategy. Whether or not researchers are sufficiently aware of the problems accompanying
such preliminary claims, the real issue is how to get from these provisional, coarse-grained
claims about “the microbiome” to more accurate claims about the causally relevant factors
within the microbiome.
(ii) Another, neglected, problem for microbiome researchers who do decompose the micro-
bial components is to also decompose the phenotype into relevant entities and activities for the
causal claims they are trying to make. Not only the chicken sandwich, but also the signs and
types of food poisoning should be distinguished for the relevant claim that “Salmonella causes
food poisoning”. This remark emphasizes a different problem for the field of microbiome re-
search: researchers trying to produce new knowledge in a field are specialized in this field.
Usually, they rely on established, accepted knowledge in other fields, both out of cautiousness
and non-competence. Those who study the phenotype normally do not hypothesize any bold
decomposition of the microbiome, and vice versa.
(iii) While researchers might already be aware of the need to decompose the microbiome in
order to understand their causal implications, the methodological and disciplinary boundaries
might be forcing them into certain frameworks. For instance, the majority of microbiome
studies uses sequence data to provide a taxonomic profile based on 16S rRNA. Microbiome-
wide association studies have focused on linking taxonomic composition to diseases (Gilbert
et al., 2016). However, with researchers increasingly realizing that looking at taxonomic com-
position based on 16S rRNA sequencing might not the best way to identify the explanatorily
relevant causal factors within the microbiome, they can benefit from a conceptual clarification
of how to decompose microbiome structure and function. Taxonomic and genomic profiling
remain the major approaches in the field, but the call for alternative techniques and approaches
is getting louder, e.g., (Ellegaard and Engel, 2016). Pre-existing ways of decomposing micro-
biome and phenotypes independently from each other might not be enough. A conceptual
clarification of compositional, functional, outcome-oriented, and causal core aspects (Lynch
et al., 2019, 11) of microbiomes will certainly enrich the debate in this field. While some
ways of decomposition exist for certain phenotypes (e.g., “hallmarks” of cancer (Hanahan and
Weinberg, 2000), aging (Lo´pez-Otı´n et al., 2013), etc.), there is no such standard for obesity,
mental health, or even something seemingly simple as ulcers. In some cases, a phenotype is
clear-cut enough not to require any further conceptual decomposition, but in many other cases,
decomposition of the phenotype contributes a lot to the clarification needed to understand the
causal role of the (decomposed) microbiome.
(iv) Not only do phenotypic effects often have to be also decomposed besides their pre-
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sumptive microbial causes, they also need to be decomposed together. The complete, cor-
rect formulation is not that ‘something in microbiome µ causes phenotype ϕ’, but rather that
‘something in µ is causally linked to something in a given ϕ’. The point is not only that a
causal claim should achieve specificity in the sense of a one-to-one mapping (as Lynch et al.
(2019, 7, Box 1) correctly point out), but rather that decomposition must often be equally per-
formed on the putative cause and its putative effect for the relation to be strongly established.
Four different situations illustrate that point.
First, some health conditions are semantically the same but may prove biologically differ-
ent. This view is commonly held in neurobiological psychiatry as regards conditions such as
mood disorders (mainly anxiety and depression), typically diagnosed through behavioral and
cognitive symptoms whose detection, and maybe also definition, heavily depends on language.
What one wants to causally associate with a remarkable feature of the microbiome is not ev-
erything that falls under the name ‘depression’ or ‘obesity’, but only one of its biologically
specific subtypes. The discovery of a possibly important causal factor like dysbiosis should
typically lead to the decomposition of a semantically strong, but biologically weak, entity.
Second, there are also various known phenotypes of the same condition. It is not just a
matter of continuity of states from leanness to obesity. Indeed, although it is a minor subject
of investigation, different phenotypes of obesity may be defined by the morphological distri-
bution of fat in the organism. This difference has also been associated with differences in
metabolism, in turn associated to differential cardiovascular risk (Pajunen et al., 2011). Any
of these distinctions may prove crucial in the investigation of the causal relationship with the
microbiome. This has time and again proven to be the case in other contexts, such as precisely
during the discovery of the role of Helicobacter pylori in peptic ulcer, and it is a useful lesson
to be drawn from history.
Third, different pathways may lead to the same pathological outcome. All instances of pep-
tic ulcer do not necessarily stem from the same origin, e.g., H. pylori infection, tobacco use,
and consumption of non-steroidal anti-inflammatory drugs. Pathways matter to the definition
of a health outcome as one disease or distinct forms of a disease: they are not treated with the
same therapeutic strategies, and are often not named the same.
Fourth, a disease may consist in the same loss of balance caused by any defect in any of its
components or determinants, as is typically the case in peptic ulcer, in obesity, and probably
in mood disorders as well. The decomposition of the cause should be associated with the
decomposition of the effect – typically a kind of balance – for any causal claim to be precise
enough. Moreover, it is often – if not always – only through the discovery of a specific cause,
that the balance in question comes to be adequately described.
(v) Finally, we see an opportunity for philosophers to advance the field beyond the two-
place relation of cause and effect. Figure 1 contrasts the provisional picture of un-decomposed
causal claims with that of one in which both microbiome and phenotype are decomposed rel-
ative to each other. This picture might also be expanded by external common causes and
internal causal connections. As soon as the interactions become more complex, resulting in
dynamic chains and networks, looking for two-place cause-effect relations might no longer
provide the adequate “level of explanation” (Woodward, 2010) or “causal locus” (O’Malley
and Skillings, 2018, 251). Dynamic, mechanistic, and non-causal explanations might prove to
be useful tools for these very issues. Establishing a causal relation between a microbial and
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Figure 1: Causal mapping between microbiome µ and phenotype ϕ , (a) un-decomposed and
(b) decomposed.
phenotypic component might be less explanatorily relevant than the mechanisms and topolo-
gies of interaction networks, where the identity of individual components becomes less impor-
tant. That something causes something else will be hard to establish in complex and dynamic
interactions. However, it is possible to define clear-cut cause-effect relations between some
decomposed microbial and phenotypic components – when they are properly decomposed
relative to each other.
A network- and ecology-based perspective needs to be more refined than the kind that
Lynch et al. criticize: “this ecological version simply distributes all causality across the whole
microbiome” (2019, 20). A middle ground position could be to have a specific microbial
interaction network that can explain (perhaps non-causally) the aspect of a phenomenon in
question, as can be found in philosophical accounts of topological explanations, e.g., (Hune-
man, 2010; Kostic´, 2018). The characteristics of an interventionist account of causal expla-
nation – specificity, stability, and proportionality (Lynch et al., 2019, 7) – will certainly be
improved by making causal claims in which microbial and phenotypic causes and effects
have been properly decomposed. They might even be better met by other accounts beyond
the framework of Koch’s postulates and binary causation relations: “although mechanism-
oriented research can indeed provide causal explanations of particular phenomena, it is clear
there are many instances when causal complexity overwhelms straightforward mechanistic ac-
counts” (O’Malley and Skillings, 2018, 254). For a better mechanistic understanding, a dual
decomposition of both microbiome and phenotypic effects could at least improve the situation:
“Knowledge of a mechanism in the biological sciences is usually more useful for explanation,
prediction, and control than merely being able to label something as a cause” (Darden, 2013,
20).
Taken together, we propose a dual decomposition strategy to enrich the debate about a philo-
sophical clarification of concepts and explanatory strategies in microbiome research, which
should contribute to a better understanding – and experimental testing – of causal claims about
the microbiome. We share this goal with the authors of the target paper (Lynch et al., 2019,
this issue) and appreciate the debate that it triggers.
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